# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-007494
Filing Date
2025-05-13
Accepted
2025-05-13 07:45:36
Documents
108
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | xoma-20250331x10q.htm iXBRL | 10-Q | 2401099
2 | EX-31.1 | xoma-20250331xex31d1.htm | EX-31.1 | 10492
3 | EX-31.2 | xoma-20250331xex31d2.htm | EX-31.2 | 10521
4 | EX-32.1 | xoma-20250331xex32d1.htm | EX-32.1 | 8553
| Complete submission text file | 0001558370-25-007494.txt |  | 12409591

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | xoma-20250331.xsd | EX-101.SCH | 102716
6 | EX-101.CAL | xoma-20250331_cal.xml | EX-101.CAL | 83333
7 | EX-101.DEF | xoma-20250331_def.xml | EX-101.DEF | 504225
8 | EX-101.LAB | xoma-20250331_lab.xml | EX-101.LAB | 759735
9 | EX-101.PRE | xoma-20250331_pre.xml | EX-101.PRE | 700817
111 | EXTRACTED XBRL INSTANCE DOCUMENT | xoma-20250331x10q_htm.xml | XML | 2215181

Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Royalty Corp (Filer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39801 | Film No.: 25937181
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)